[{"AccountsPayableCurrent_0_Q1_USD":98000000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":15600000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1400000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.28,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-7900000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":4900000.0,"RepaymentsOfLongTermLinesOfCredit_1_Q1_USD":25000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":163300000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q1_USD":-100000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q1_USD":0.87,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q1_USD":0.88,"StockholdersEquityOther_1_Q1_USD":-2100000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":-1600000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":464700000.0,"OtherLiabilitiesCurrent_0_Q1_USD":407200000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-15800000.0,"LaborAndRelatedExpense_1_Q1_USD":679100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":177000000.0,"RestrictedCashCurrent_0_Q1_USD":56700000.0,"OtherAssetsCurrent_0_Q1_USD":79500000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q1_USD":15500000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q1_USD":5700000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":800000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":108700000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7100000.0,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":330000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":17400000.0,"DueToAffiliateNoncurrent_0_Q1_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1182000000.0,"RestrictedCashNoncurrent_0_Q1_USD":15400000.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q1_USD":34000000.0,"PaymentsToMinorityShareholders_1_Q1_USD":19100000.0,"PaymentsToAcquireInterestInSubsidiariesAndAffiliates_1_Q1_USD":162300000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":1100000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":15600000.0,"PartnersCapitalAccountContributions_1_Q1_USD":5800000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-7700000.0,"OriginationOfNotesReceivableFromRelatedParties_1_Q1_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":267900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":235100000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":40800000.0,"NumberOfStatesInWhichEntityOperates_0_Q1_state":37.0,"NumberOfOperatingSegments_1_Q1_segment":2.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q1_USD":2000000.0,"NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_1_Q1_USD":19700000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q1_USD":40200000.0,"IncomeLossFromSubsidiariesBeforeTax_1_Q1_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1_Q1_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1_Q1_USD":0.0,"IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_1_Q1_USD":21700000.0,"FinanceLeaseLiability_0_Q1_USD":381200000.0,"DebtAndCapitalLeaseObligations_0_Q1_USD":3362100000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":29000000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":87000000.0,"IncreaseDecreaseInAccruedSalaries_1_Q1_USD":-24000000.0,"InterestExpense_1_Q1_USD":43200000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":1443900000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2003300000.0,"ProfitLoss_1_Q1_USD":108700000.0,"ProceedsFromRelatedPartyDebt_1_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":83500000.0,"NetIncomeLoss_1_Q1_USD":87000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":29300000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-83000000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":71100000.0,"LiabilitiesCurrent_0_Q1_USD":586200000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":6137700000.0,"Liabilities_0_Q1_USD":4306500000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":36600000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":27100000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":135900000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":35600000.0,"CostsAndExpenses_1_Q1_USD":1001800000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":104900000.0,"AssetsCurrent_0_Q1_USD":784500000.0,"Assets_0_Q1_USD":6137700000.0,"AccountsReceivableNetCurrent_0_Q1_USD":543400000.0,"ShareBasedCompensation_1_Q1_USD":7100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":99600000.0,"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1_Q1_USD":-79500000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-109600000.0,"EarningsPerShareDiluted_1_Q1_USD":0.87,"DividendsCommonStockCash_1_Q1_USD":27900000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":58800000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":1400000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":1500000.0,"OtherCostAndExpenseOperating_1_Q1_USD":159600000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_1_Q1_USD":-100000.0,"IncomeLossFromContinuingOperations_1_Q1_USD":87100000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":21700000.0,"NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1_Q1_USD":106700000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":87000000.0,"SuppliesExpense_1_Q1_USD":45700000.0,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_1_Q1_USD":-100000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q1_USD":46300000.0,"OtherAssetsNoncurrent_0_Q1_USD":303700000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":21700000.0,"MinorityInterest_0_Q1_USD":353300000.0,"LitigationSettlementExpense_1_Q1_USD":2800000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":108800000.0,"Goodwill_0_Q1_USD":2312100000.0,"EarningsPerShareBasic_1_Q1_USD":0.88,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":1797200000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-1900000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q1_USD":3321900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":98200000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1_Q1_USD":300000.0,"Ticker":"EHC","CIK":"785161","name":"ENCOMPASS HEALTH CORP","OfficialName":"Encompass Health Corporation Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7151596423.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20200511"}]